Over the last 7 days, the Australian market has remained flat, but it is up 6.9% over the past year with earnings forecasted to grow by 11% annually. In this environment, identifying growth companies with high insider ownership can be beneficial as these stocks often reflect strong internal confidence and alignment of interests between management and shareholders.
Top 10 Growth Companies With High Insider Ownership In Australia
| Name | Insider Ownership | Earnings Growth |
| Wisr (ASX:WZR) | 12.2% | 91.2% |
| Pointerra (ASX:3DP) | 23.4% | 110.3% |
| Newfield Resources (ASX:NWF) | 31.5% | 72.1% |
| Image Resources (ASX:IMA) | 22.2% | 92.5% |
| Findi (ASX:FND) | 33.6% | 91.2% |
| Emerald Resources (ASX:EMR) | 18.1% | 35.9% |
| Echo IQ (ASX:EIQ) | 18% | 49.9% |
| BlinkLab (ASX:BB1) | 35.5% | 101.4% |
| Adveritas (ASX:AV1) | 18.8% | 96.8% |
| Acrux (ASX:ACR) | 15.1% | 121.1% |
We'll examine a selection from our screener results.
Energy One (ASX:EOL)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Energy One Limited provides software products, outsourced operations, and advisory services to wholesale energy, environmental, and carbon trading markets in Australasia and Europe, with a market cap of A$578.44 million.
Operations: The company's revenue primarily comes from the Energy Software Industry, totaling A$61.12 million.
Insider Ownership: 22.7%
Energy One has shown substantial growth, with earnings increasing by 308.7% over the past year and forecasted annual earnings growth of 24.9%, outpacing the Australian market's average. Despite significant insider selling recently, its addition to the S&P/ASX Emerging Companies Index highlights investor confidence. Revenue grew to A$61.36 million from A$52.46 million last year, and net income rose to A$5.89 million from A$1.44 million, indicating strong financial performance amidst high insider ownership dynamics.
- Click here to discover the nuances of Energy One with our detailed analytical future growth report.
- Upon reviewing our latest valuation report, Energy One's share price might be too optimistic.
Magnetic Resources (ASX:MAU)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Magnetic Resources NL is involved in the exploration of mineral tenements in Western Australia and has a market cap of A$383.84 million.
Operations: Magnetic Resources NL's revenue segments are not specified in the provided text.
Insider Ownership: 37.5%
Magnetic Resources, recently added to the S&P/ASX Emerging Companies Index, is set to become profitable within three years with earnings projected to grow 132.84% annually. Despite minimal revenue of A$199K and a net loss of A$14.22 million for the year ended June 2025, its high forecasted return on equity of 33% in three years suggests potential growth. The recent A$35 million follow-on equity offering underlines investor interest amidst high insider ownership dynamics.
- Dive into the specifics of Magnetic Resources here with our thorough growth forecast report.
- Insights from our recent valuation report point to the potential overvaluation of Magnetic Resources shares in the market.
PYC Therapeutics (ASX:PYC)
Simply Wall St Growth Rating: ★★★★★☆
Overview: PYC Therapeutics Limited is an Australian drug-development company focused on discovering and developing novel RNA therapeutics for treating genetic diseases, with a market cap of A$577.43 million.
Operations: The company's revenue is primarily derived from its activities in the discovery and development of novel RNA therapeutics, amounting to A$23.49 million.
Insider Ownership: 38.3%
PYC Therapeutics is poised for profitability within three years, with earnings projected to grow 33.76% annually and revenue expected to outpace the market at 10.3% per year. Despite a net loss of A$50.3 million for the fiscal year ending June 2025, its shares trade significantly below estimated fair value, hinting at potential upside. However, recent auditor concerns about its ability to continue as a going concern and past shareholder dilution warrant caution amidst high insider ownership dynamics.
- Take a closer look at PYC Therapeutics' potential here in our earnings growth report.
- The analysis detailed in our PYC Therapeutics valuation report hints at an inflated share price compared to its estimated value.
Next Steps
- Reveal the 110 hidden gems among our Fast Growing ASX Companies With High Insider Ownership screener with a single click here.
- Ready For A Different Approach? The latest GPUs need a type of rare earth metal called Neodymium and there are only 31 companies in the world exploring or producing it. Find the list for free.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Magnetic Resources might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com